A detailed history of Cetera Investment Advisers transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Cetera Investment Advisers holds 21,775 shares of LXRX stock, worth $15,460. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21,775
Holding current value
$15,460
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$1.51 - $2.39 $32,880 - $52,042
21,775 New
21,775 $34,000
Q1 2024

May 24, 2024

BUY
$1.3 - $3.58 $13,877 - $38,216
10,675 New
10,675 $25,000
Q2 2021

Aug 13, 2021

SELL
$4.12 - $5.87 $85,238 - $121,444
-20,689 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$3.45 - $9.09 $71,377 - $188,063
20,689 New
20,689 $121,000

Others Institutions Holding LXRX

About LEXICON PHARMACEUTICALS, INC.


  • Ticker LXRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 188,726,000
  • Market Cap $134M
  • Description
  • Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...
More about LXRX
Track This Portfolio

Track Cetera Investment Advisers Portfolio

Follow Cetera Investment Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Investment Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Investment Advisers with notifications on news.